C01EB18 • ranolazine • Cardiovascular system | Other cardiac preparations
Ranolazine is a medication used to treat chronic angina, a condition characterized by chest pain caused by insufficient blood flow to the heart. It works by improving the efficiency of cardiac metabolism without significantly affecting heart rate or blood pressure.
The medication is taken orally, usually in extended-release tablet form, and should be used as directed by your doctor. It is important not to stop the treatment without consulting your doctor.
Side effects may include dizziness, nausea, constipation, or headache. In rare cases, severe adverse effects such as arrhythmias or allergic reactions may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney or liver impairment, to ensure the safe use of ranolazine.
Substance: ranolazine
Date of last drug list: 01-07-2013
Commercial code: W53299001
Concentration: 750mg
Pharmaceutical form: prolonged-release film-coated tablets
Quantity: 60
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).